M
Michael A. Polis
Researcher at National Institutes of Health
Publications - 168
Citations - 14186
Michael A. Polis is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Viral load & Hepatitis C virus. The author has an hindex of 55, co-authored 168 publications receiving 13766 citations. Previous affiliations of Michael A. Polis include Uniformed Services University of the Health Sciences & University of Maryland, Baltimore.
Papers
More filters
Journal ArticleDOI
Changes in thymic function with age and during the treatment of HIV infection
Daniel C. Douek,Richard D. McFarland,Phillip H. Keiser,Earl A. Gage,Janice M. Massey,Barton F. Haynes,Michael A. Polis,Ashley T. Haase,Mark B. Feinberg,John L. Sullivan,Beth D. Jamieson,Jerome A. Zack,Louis J. Picker,Richard A. Koup +13 more
TL;DR: It is found that, although thymic function declines with age, substantial output is maintained into late adulthood and this results indicate that the adult thymus can contribute to immune reconstitution following HAART.
Journal ArticleDOI
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression
Richard T. Davey,Niranjan Bhat,Christian Yoder,Tae Wook Chun,Julia A. Metcalf,Robin Dewar,Ven Natarajan,Richard A. Lempicki,Joseph W. Adelsberger,Kirk D. Miller,Joseph A. Kovacs,Michael A. Polis,Robert E. Walker,Judith Falloon,Henry Masur,Dennis Gee,Michael Baseler,Dimiter S. Dimitrov,Anthony S. Fauci,H. Clifford Lane +19 more
TL;DR: Ex vivo labeling with BrdUrd showed that CD4 and CD8 cell turnover increased after withdrawal of HAART and correlated with viral load whereas lymphocyte turnover decreased after reinitiation of drug treatment, and Virologic relapse occurs rapidly in patients who discontinue suppressive drug therapy.
Journal ArticleDOI
New Real-Time Reverse Transcriptase-Initiated PCR Assay with Single-Copy Sensitivity for Human Immunodeficiency Virus Type 1 RNA in Plasma
Sarah Palmer,Ann Wiegand,Frank Maldarelli,Holly Bazmi,JoAnn M. Mican,Michael A. Polis,Robin L. Dewar,Angeline Planta,Shuying Liu,Julia A. Metcalf,John W. Mellors,John M. Coffin +11 more
TL;DR: An internally controlled real-time reverse transcriptase-initiated PCR assay that quantifies HIV-1 RNA concentrations down to 1 copy per ml of plasma and had a greater sensitivity than the other assays shown, allowing better characterization of persistent viremia in patients who are receiving antiretroviral therapy and whose HIV- 1 RNA levels are suppressed to below the detection limits of present assays.
Journal ArticleDOI
Cryptococcosis in the acquired immunodeficiency syndrome.
Joseph A. Kovacs,Andrea Kovacs,Michael A. Polis,W. Craig Wright,Vee J. Gill,Carmelita U. Tuazon,Edward P. Gelmann,H. Clifford Lane,Robert Longfield,Gary Overturf,Abe M. Macher,Anthony S. Fauci,Joseph E. Parrillo,John E. Bennett,Henry Masur +14 more
TL;DR: Cryptococcosis in patients with the acquired immunodeficiency syndrome is a debilitating disease that does not respond to conventional therapy; earlier diagnosis or long-term suppressive therapy may improve the prognosis.
Journal ArticleDOI
Guidelines for preventing opportunistic infections among HIV-infected persons - 2002
Henry Masur,Jonathan E. Kaplan,King K. Holmes,Beverly Alston,Miriam J. Alter,Neil M. Ampel,Jean Anderson,A. Cornelius Baker,David A Barr,John G. Bartlett,John E. Bennett,Constance A. Benson,William A. Bower,Samuel A. Bozzette,John T. Brooks,Victoria A. Cargill,Kenneth G. Castro,Richard E. Chaisson,David A. Cooper,Clyde S. Crumpacker,Judith S. Currier,Kevin M. DeCock,Lawrence Deyton,Scott F. Dowell,W. Lawrence Drew,William Duncan,Mark S. Dworkin,Clare A. Dykewicz,Robert W Eisinger,Tedd Ellerbrock,Wafaa El-Sadr,Judith Feinberg,Kenneth A. Freedberg,Keiji Fukuda,Hansjakob Furrer,Jose M. Gatell,John W. Gnann,Mark J. Goldberger,Sue Goldie,Eric P. Goosby,Fred M. Gordin,Peter A. Gross,Rana Hajjeh,Richard Hafner,Diane Havlir,S D Holmberg,David R. Holtgrave,Thomas M. Hooton,Douglas A. Jabs,Mark A. Jacobson,Harold Jaffe,Edward N. Janoff,Jeffrey M. Jones,Dennis D. Juranek,Mari M. Kitahata,Joseph A. Kovacs,Catherine Leport,Myron J. Levin,Juan C. Lopez,Jens D Lundgren,Michael Marco,Eric Mast,Douglas L. Mayers,Lynne M. Mofenson,Julio Montaner,Richard A. Moore,Thomas Navin,James D. Neaton,Charles Nelson,Joseph F. O'Neill,Joel Palefsky,Alice Pau,Phil Pellett,John P. Phair,Steve Piscitelli,Michael A. Polis,Thomas C. Quinn,William C. Reeves,Peter Reiss,David Rimland,Anne Schuchat,Cynthia L. Sears,Leonard B. Seeff,Kent A. Sepkowitz,Kenneth E. Sherman,Thomas G. Slama,Elaine M. Sloand,Stephen A. Spector,John A. Stewart,David L. Thomas,Timothy M. Uyeki,Russell Van Dyke,M. Elsa Villarino,Anna Wald,D. Heather Watts,L. Joseph Wheat,Paige L. Williams,Thomas C. Wright +97 more
TL;DR: This fourth edition of the guidelines for preventing opportunistic infections (OIs) among persons infected with human immunodeficiency virus (HIV) is intended for clinicians and other health-care providers who care for HIV-infected persons.